Transatlantique Private Wealth LLC lifted its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 98.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 6,037 shares of the conglomerate’s stock after acquiring an additional 2,989 shares during the period. Transatlantique Private Wealth LLC’s holdings in Danaher were worth $1,382,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of the company. Enterprise Financial Services Corp grew its position in shares of Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after acquiring an additional 46 shares during the last quarter. Kennebec Savings Bank boosted its position in shares of Danaher by 1.4% during the 4th quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after purchasing an additional 46 shares in the last quarter. Revolve Wealth Partners LLC boosted its position in shares of Danaher by 2.6% during the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after purchasing an additional 47 shares in the last quarter. High Note Wealth LLC boosted its position in shares of Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares in the last quarter. Finally, Kestra Private Wealth Services LLC boosted its position in shares of Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after purchasing an additional 48 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Danaher Trading Up 1.3%
Shares of Danaher stock opened at $178.40 on Thursday. The company’s fifty day simple moving average is $181.40 and its 200-day simple moving average is $206.59. The company has a market cap of $126.26 billion, a price-to-earnings ratio of 34.51, a PEG ratio of 2.35 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s payout ratio is currently 30.95%.
Analyst Upgrades and Downgrades
A number of analysts have commented on DHR shares. Citigroup started coverage on shares of Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Royal Bank Of Canada started coverage on shares of Danaher in a research report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price target for the company. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. JPMorgan Chase & Co. cut their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Twenty research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $235.14.
View Our Latest Research Report on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- As AI Data Breaches Become More Common, This Cybersecurity ETF Is SurgingAI
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
